Keogh D P, Smith S L
Department of Biological Sciences, Bowling Green State University, OH 43403.
Biochem Biophys Res Commun. 1991 Apr 15;176(1):522-7. doi: 10.1016/0006-291x(91)90956-8.
The non-steroidal ecdysone agonist RH 5849 (1,2-dibenzoyl-1-tert-butylhydrazine) was found to inhibit in a dose-response and apparently competitive fashion the cytochrome P-450 dependent ecdysone 20-monooxygenase activity in the midgut of wandering stage last instar larvae of the tobacco hornworn, Manduca sexta. More effectively on a per molar basis than the naturally occurring molting hormones ecdysone and 20-hydroxyecdysone, RH 5849 was also found to elicit the dramatic 50-fold increase in midgut steroid hydroxylase activity (which normally occurs with the onset of the wandering stage) when injected into competent head or thoracic ligated pre-wandering last instar larvae. These data support and extend the potential usefulness of RH 5849 as a pharmacological probe for further investigating the actions of ecdysteroids and their role(s) in the regulation of ecdysteroid monooxygenases.
非甾体类蜕皮激素激动剂RH 5849(1,2 - 二苯甲酰基 - 1 - 叔丁基肼)被发现以剂量反应且明显具有竞争性的方式抑制烟草天蛾末龄幼虫化蛹阶段中肠内细胞色素P - 450依赖性蜕皮激素20 - 单加氧酶的活性。与天然存在的蜕皮激素蜕皮酮和20 - 羟基蜕皮酮相比,按每摩尔计算,RH 5849更有效,当将其注射到有能力的头部或胸部结扎的化蛹前末龄幼虫中时,还能引发中肠类固醇羟化酶活性急剧增加50倍(这种增加通常在化蛹阶段开始时出现)。这些数据支持并扩展了RH 5849作为一种药理学探针在进一步研究蜕皮甾体的作用及其在蜕皮甾体单加氧酶调节中的作用方面的潜在用途。